|

Pulmonary Vascular Disease and Cardiac Performance in Extreme Preterm Infants

RECRUITINGSponsored by McGill University Health Centre/Research Institute of the McGill University Health Centre
Actively Recruiting
SponsorMcGill University Health Centre/Research Institute of the McGill University Health Centre
Started2019-10-12
Est. completion2023-11-30
Eligibility
Age7 Days – 5 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT04114435

Summary

Pulmonary vascular disease and cardiac performance in extreme preterm infants: A prospective cross-sectional study

Eligibility

Age: 7 Days – 5 YearsHealthy volunteers accepted
Inclusion Criteria:

* Infants born at \<29 weeks' gestational age admitted to the NICU
* All infants born at \<29 weeks' gestational age followed at MCH clinic after an admission in the NICU for prematurity \<29 weeks

Exclusion Criteria:

* Congenital heart disease (except an atrial (ASD) or ventricular septal defect (VSD), or a patent ductus arteriosus (PDA))
* Congenital severe lung or airway malformation (choanal atresia, trachea-esophageal fistula or congenital pulmonary airway malformation)
* Genetic disorder (Trisomy 21).

Conditions2

Heart DiseasePrematurity; Extreme

Browse More Trials

Heart Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.